VolitionRX Developing Blood Test To Avoid Invasive Colonoscopy

Bloomberg Markets AM with Pimm Fox and Lisa Abramowicz.

GUEST: VolitionRX Group CEO Cameron Reynolds on developing a colon cancer test that could soon mean no more invasive colonoscopies.

Running time 07:42

Before it's here, it's on the Bloomberg Terminal. LEARN MORE